annual EBITDA:
$109.91M+$201.22M(+220.36%)Summary
- As of today (June 26, 2025), KRYS annual EBITDA is $109.91 million, with the most recent change of +$201.22 million (+220.36%) on December 31, 2024.
- During the last 3 years, KRYS annual EBITDA has risen by +$176.14 million (+265.95%).
- KRYS annual EBITDA is now at all-time high.
Performance
KRYS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$37.81M-$5.12M(-11.93%)Summary
- As of today (June 26, 2025), KRYS quarterly EBITDA is $37.81 million, with the most recent change of -$5.12 million (-11.93%) on March 31, 2025.
- Over the past year, KRYS quarterly EBITDA has increased by +$30.39 million (+409.24%).
- KRYS quarterly EBITDA is now -11.93% below its all-time high of $42.93 million, reached on December 31, 2024.
Performance
KRYS quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$140.29M+$30.39M(+27.65%)Summary
- As of today (June 26, 2025), KRYS TTM EBITDA is $140.29 million, with the most recent change of +$30.39 million (+27.65%) on March 31, 2025.
- Over the past year, KRYS TTM EBITDA has increased by +$189.17 million (+387.03%).
- KRYS TTM EBITDA is now at all-time high.
Performance
KRYS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KRYS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +220.4% | +409.2% | +387.0% |
| 3 y3 years | +265.9% | +256.2% | +283.4% |
| 5 y5 years | +623.6% | +867.1% | +756.9% |
KRYS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +194.1% | -11.9% | +203.4% | at high | +202.8% |
| 5 y | 5-year | at high | +194.1% | -11.9% | +203.4% | at high | +202.8% |
| alltime | all time | at high | +194.1% | -11.9% | +203.4% | at high | +202.8% |
KRYS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $37.81M(-11.9%) | $140.29M(+27.6%) |
| Dec 2024 | $109.91M(-220.4%) | $42.93M(+17.7%) | $109.91M(+52.9%) |
| Sep 2024 | - | $36.46M(+57.9%) | $71.87M(+566.8%) |
| Jun 2024 | - | $23.09M(+210.9%) | $10.78M(-122.1%) |
| Mar 2024 | - | $7.42M(+51.7%) | -$48.88M(-46.5%) |
| Dec 2023 | -$91.32M(-21.8%) | $4.89M(-119.9%) | -$91.31M(-30.1%) |
| Sep 2023 | - | -$24.63M(-32.7%) | -$130.56M(-4.3%) |
| Jun 2023 | - | -$36.57M(+4.4%) | -$136.41M(+6.9%) |
| Mar 2023 | - | -$35.01M(+1.9%) | -$127.62M(+9.2%) |
| Dec 2022 | -$116.81M(+76.4%) | -$34.35M(+12.7%) | -$116.81M(+12.0%) |
| Sep 2022 | - | -$30.48M(+9.7%) | -$104.27M(+17.7%) |
| Jun 2022 | - | -$27.78M(+14.7%) | -$88.60M(+15.8%) |
| Mar 2022 | - | -$24.21M(+11.0%) | -$76.52M(+15.8%) |
| Dec 2021 | -$66.23M(+118.5%) | -$21.81M(+47.3%) | -$66.09M(+22.0%) |
| Sep 2021 | - | -$14.81M(-5.7%) | -$54.18M(+11.7%) |
| Jun 2021 | - | -$15.70M(+13.9%) | -$48.51M(+23.8%) |
| Mar 2021 | - | -$13.78M(+39.3%) | -$39.17M(+29.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$30.32M(+44.4%) | -$9.89M(+8.3%) | -$30.32M(+15.5%) |
| Sep 2020 | - | -$9.13M(+43.6%) | -$26.24M(+18.5%) |
| Jun 2020 | - | -$6.36M(+29.1%) | -$22.15M(+3.7%) |
| Mar 2020 | - | -$4.93M(-15.3%) | -$21.36M(+1.7%) |
| Dec 2019 | -$20.99M(+78.3%) | -$5.82M(+15.4%) | -$20.99M(+8.6%) |
| Sep 2019 | - | -$5.04M(-9.5%) | -$19.33M(+12.2%) |
| Jun 2019 | - | -$5.57M(+22.1%) | -$17.22M(+22.3%) |
| Mar 2019 | - | -$4.56M(+9.7%) | -$14.08M(+19.6%) |
| Dec 2018 | -$11.78M(+147.9%) | -$4.16M(+41.7%) | -$11.78M(+29.4%) |
| Sep 2018 | - | -$2.93M(+21.0%) | -$9.10M(+10.2%) |
| Jun 2018 | - | -$2.42M(+7.3%) | -$8.26M(+26.2%) |
| Mar 2018 | - | -$2.26M(+52.2%) | -$6.54M(+37.8%) |
| Dec 2017 | -$4.75M(+316.2%) | -$1.48M(-28.9%) | -$4.75M(+22.3%) |
| Sep 2017 | - | -$2.09M(+193.3%) | -$3.88M(+83.4%) |
| Jun 2017 | - | -$712.00K(+53.4%) | -$2.12M(+50.7%) |
| Mar 2017 | - | -$464.00K(-25.0%) | -$1.41M(+49.3%) |
| Dec 2016 | -$1.14M | -$619.00K(+92.2%) | -$941.00K(+192.2%) |
| Sep 2016 | - | -$322.00K | -$322.00K |
FAQ
- What is Krystal Biotech annual EBITDA?
- What is the all time high annual EBITDA for Krystal Biotech?
- What is Krystal Biotech annual EBITDA year-on-year change?
- What is Krystal Biotech quarterly EBITDA?
- What is the all time high quarterly EBITDA for Krystal Biotech?
- What is Krystal Biotech quarterly EBITDA year-on-year change?
- What is Krystal Biotech TTM EBITDA?
- What is the all time high TTM EBITDA for Krystal Biotech?
- What is Krystal Biotech TTM EBITDA year-on-year change?
What is Krystal Biotech annual EBITDA?
The current annual EBITDA of KRYS is $109.91M
What is the all time high annual EBITDA for Krystal Biotech?
Krystal Biotech all-time high annual EBITDA is $109.91M
What is Krystal Biotech annual EBITDA year-on-year change?
Over the past year, KRYS annual EBITDA has changed by +$201.22M (+220.36%)
What is Krystal Biotech quarterly EBITDA?
The current quarterly EBITDA of KRYS is $37.81M
What is the all time high quarterly EBITDA for Krystal Biotech?
Krystal Biotech all-time high quarterly EBITDA is $42.93M
What is Krystal Biotech quarterly EBITDA year-on-year change?
Over the past year, KRYS quarterly EBITDA has changed by +$30.39M (+409.24%)
What is Krystal Biotech TTM EBITDA?
The current TTM EBITDA of KRYS is $140.29M
What is the all time high TTM EBITDA for Krystal Biotech?
Krystal Biotech all-time high TTM EBITDA is $140.29M
What is Krystal Biotech TTM EBITDA year-on-year change?
Over the past year, KRYS TTM EBITDA has changed by +$189.17M (+387.03%)